Home · Peptides · Cagrilintide
THE PEPTIDE APP FIELD GUIDE · Metabolic SERIES FIELD SPECIMEN
Metabolic CATEGORY

Cagrilintide

THE SATIETY SIGNAL

Acylated amylin analog

Cagrilintide is an amylin-mimicking peptide that strongly suppresses appetite and slows gastric emptying, working alongside GLP-1s to boost satiety and support sustained weight loss.

Cagrilintide
Cagrilintide
Cagrilintide

Cagrilintide Evidence Snapshot

How these guides are reviewed
REGULATORY STATUS

Not FDA approved · research use only

DOSING GUIDANCE

Reviewed by our clinical team

LINKED EVIDENCE

1 research sources

CONTENT UPDATED

Sep 1, 2026

Dose and schedule recommendations shown below come from The Peptide App Clinical Team. Research links are provided so readers can inspect the supporting evidence directly. Review the sources.

Quick Answers About Cagrilintide

◆

Is Cagrilintide FDA approved?

No. This profile records Cagrilintide as not FDA approved and for research use only.

MORE CONTEXT ›

Review the regulatory and source details on this page for the current context.

◆

What dose does The Peptide App Clinical Team recommend for Cagrilintide?

Dose: 2.4 mg once weekly (subcutaneous).

MORE CONTEXT ›

Schedule: weekly. Cycle: 8+ weeks (ongoing treatment). This is clinical-team guidance for reference and does not replace individualized instructions from a licensed clinician.

◆

What research supports this Cagrilintide guide?

This guide links to 1 curated or current research sources.

MORE CONTEXT ›

Open the research section to inspect the source titles, publication details, study types, and available abstracts directly.

Studied Effects & Mechanisms

Appetite Control

Activates satiety centers in the brain to reduce hunger

Gastric Slowing

Delays stomach emptying so you feel full longer

Blood Sugar

Suppresses glucagon and improves insulin sensitivity

People with obesity seeking medical weight loss
Type 2 diabetics needing better glucose control
Those who have plateaued on GLP-1 drugs alone
Anyone needing appetite suppression
People with metabolic syndrome

Cagrilintide Research

Live research temporarily unavailable

The live research feed did not return papers for this page. The curated references below remain available for crawlable source context.